BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10768157)

  • 21. [Vigabatrin in childhood epilepsy--personal experience].
    Zubcević S; Gavranović M; Catibusić F; Uzicanin S; Buljina A
    Med Arh; 1999; 53(3 Suppl 2):63-5. PubMed ID: 10758766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice].
    van der Zwan A; van der Zwan A
    Ned Tijdschr Geneeskd; 1994 Sep; 138(37):1859-63. PubMed ID: 7935922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.
    Mattson RH; Cramer JA; Collins JF
    N Engl J Med; 1992 Sep; 327(11):765-71. PubMed ID: 1298221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the indication of vigabatrin in children with refractory epilepsy.
    Lortie A; Chiron C; Dumas C; Mumford JP; Dulac O
    J Child Neurol; 1997 Jun; 12(4):253-9. PubMed ID: 9203067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?
    McKee PJ; Blacklaw J; Friel E; Thompson GG; Gillham RA; Brodie MJ
    Epilepsia; 1993; 34(5):937-43. PubMed ID: 8404750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P; Alving J; Gram L; Beck S
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.
    Luszczki JJ; Czuczwar SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):529-38. PubMed ID: 17204358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood.
    Dimova PS; Korinthenberg R
    Pediatr Neurol; 1999 Nov; 21(5):802-7. PubMed ID: 10593670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vigabatrin and epilepsy: lessons learned.
    Wild JM; Ahn HS; Baulac M; Bursztyn J; Chiron C; Gandolfo E; Safran AB; Schiefer U; Perucca E
    Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vigabatrin in intractable childhood epilepsy: a retrospective study.
    Gibbs JM; Appleton RE; Rosenbloom L
    Pediatr Neurol; 1992; 8(5):338-40. PubMed ID: 1418176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures.
    Velasco F; Carrillo-Ruiz JD; Brito F; Velasco M; Velasco AL; Marquez I; Davis R
    Epilepsia; 2005 Jul; 46(7):1071-81. PubMed ID: 16026559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil influences the anticonvulsant activity of vigabatrin and gabapentin in the timed pentylenetetrazole infusion test in mice.
    Nieoczym D; Socała K; Luszczki JJ; Czuczwar SJ; Wlaź P
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):129-35. PubMed ID: 22683320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroclinical features and long-term outcome of cryptogenic epilepsy in children with Down syndrome.
    Verrotti A; Cusmai R; Nicita F; Pizzolorusso A; Elia M; Zamponi N; Cesaroni E; Granata T; De Giorgi I; Giordano L; Grosso S; Pavone P; Franzoni E; Coppola G; Cerminara C; Curatolo P; Savasta S; Striano P; Parisi P; Romeo A; Spalice A
    J Pediatr; 2013 Dec; 163(6):1754-8. PubMed ID: 23992680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.